<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02552771</url>
  </required_header>
  <id_info>
    <org_study_id>15-162</org_study_id>
    <nct_id>NCT02552771</nct_id>
  </id_info>
  <brief_title>The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2</brief_title>
  <acronym>CAMRA</acronym>
  <official_title>A Randomized Trial of Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The Canadian Mitral Research Alliance (CAMRA-1) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ottawa Heart Institute Research Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicentre, double-armed, randomized controlled trial designed to compare mitral valve
      leaflet resection versus leaflet preservation with regards to the development of functional
      mitral stenosis following surgical repair of mitral valve prolapse. Patients will be
      randomized (1:1) to receive: (1) mitral valve repair with a leaflet resection or (2) mitral
      valve repair with leaflet preservation (using polytetrafluoroethylene neochordae), followed
      by echocardiographic and clinical assessment at 12-months following surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mitral valve repair has emerged as the preferred surgical treatment for mitral valve prolapse
      (MVP), a condition wherein the mitral valve does not close properly. One common strategy for
      mitral valve repair is leaflet resection, which involves removing part of one or both of the
      mitral leaflets that flop or bulge back (prolapse). Another strategy is leaflet preservation,
      which involves placing man-made fibers (sutures) to more securely connect the mitral leaflets
      to the papillary muscles (muscles located in the ventricle). While both strategies are
      routinely used and lead to successful mitral valve repair, there is no clear evidence as to
      whether one strategy is better than the other in terms of long term outcome. The purpose of
      this study is to determine if one repair strategy (leaflet resection versus leaflet
      preservation) leads to better longer term patient outcomes. A total of 88 patients from 6
      Canadian centres will be randomly assigned to one of the two strategies. The primary outcome
      will be functional mitral stenosis (MS) as assessed by 12-month mean mitral valve pressure
      gradient at peak exercise.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean mitral valve gradient at peak exercise 12-months following repair</measure>
    <time_frame>12 months following repair</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mitral valve area</measure>
    <time_frame>12 months following repair</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age/Sex predicted metabolic equivalent score</measure>
    <time_frame>12 months following repair</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral leaflet coaptation height</measure>
    <time_frame>12 months following repair</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walk test</measure>
    <time_frame>12 months following repair</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite MACE (major adverse cardiovascular event) end-point of recurrent MR â‰¥2+, death, or hospital re-admission for congestive heart failure within 12-months of surgery</measure>
    <time_frame>12 months following repair</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Mitral Valve Prolapse</condition>
  <arm_group>
    <arm_group_label>Mitral repair with leaflet preservation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placing man-made fibers (sutures) to more securely connect the mitral leaflets to the papillary muscles (muscles located in the ventricle).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mitral repair with leaflet resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Removal of one or both of the mitral leaflets that flop or bulge back.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mitral repair with leaflet preservation</intervention_name>
    <description>Placing man-made fibers (sutures) to more securely connect the mitral leaflets to the papillary muscles (muscles located in the ventricle).</description>
    <arm_group_label>Mitral repair with leaflet preservation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mitral repair with leaflet resection</intervention_name>
    <description>Removing one or both of the mitral leaflets that flop or bulge back.</description>
    <arm_group_label>Mitral repair with leaflet resection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with mitral regurgitation and mitral valve prolapse who are scheduled for
             elective mitral valve repair by an experienced mitral valve repair surgeon (&gt;15
             degenerative mitral valve repairs per year, with a repair rate&gt;90%, and able to
             perform mitral repair with either a leaflet resection or leaflet preservation
             strategy).

          2. Planned mitral valve repair amenable to either a leaflet resection or leaflet
             preservation surgical repair strategy

        Exclusion Criteria:

          1. Patients with anterior leaflet or commissural prolapse

          2. Patients with endocarditis or rheumatic mitral valve disease

          3. Patients with mitral annular calcification extending beyond the circumference of one
             leaflet scallop

          4. Patients with significant LV dysfunction defined as a LVEF &lt;40%

          5. Patients undergoing concomitant aortic valve surgery

          6. Patients unable to undergo bicycle ergometry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Chan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Subodh Verma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Subodh Verma, MD</last_name>
    <phone>416-864-5997</phone>
    <email>vermasu@smh.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Mazer, MD</last_name>
    <phone>416-864-5825</phone>
    <email>mazerd@smh.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memorial University</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Corey Adams, MD</last_name>
      <phone>709-777-2296</phone>
    </contact>
    <investigator>
      <last_name>Corey Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Victor Fan Chu, MD</last_name>
      <phone>1 905 523-0440</phone>
      <email>chu@HHSC.CA</email>
    </contact>
    <contact_backup>
      <last_name>Richard Whitlock, MD</last_name>
      <email>Richard.Whitlock@phri.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Victor Fan Chu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Chu, MD</last_name>
      <phone>(519) 663-3593</phone>
      <email>Michael.Chu@lhsc.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Fox</last_name>
      <phone>519-685-8500</phone>
      <phone_ext>35031</phone_ext>
      <email>Stephanie.Fox@lhsc.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Chu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Chan, MD</last_name>
      <phone>613-798-5555</phone>
      <phone_ext>14253</phone_ext>
      <email>VChan@ottawaheart.ca</email>
    </contact>
    <contact_backup>
      <last_name>Jacqueline Fortier, Msc</last_name>
      <phone>613-798-5555</phone>
      <phone_ext>18329</phone_ext>
      <email>JFortier@ottawaheart.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Vincent Chan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Subodh Verma, MD</last_name>
      <phone>(416) 864-5997</phone>
      <email>vermasu@smh.ca</email>
    </contact>
    <contact_backup>
      <last_name>Sanjay Yagnik</last_name>
      <phone>416-864-6060</phone>
      <phone_ext>6690</phone_ext>
      <email>YagnikS@smh.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Subodh Verma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGill University Health Center</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoit de Varennes, MD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>34980</phone_ext>
      <email>benoit.devarennes@muhc.mcgill.ca</email>
    </contact>
    <contact_backup>
      <last_name>Carole Albert</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>35277</phone_ext>
      <email>carole.albert@muhc.mcgill.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Benoit de Varennes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Theal M, Sleik K, Anand S, Yi Q, Yusuf S, Lonn E. Prevalence of mitral valve prolapse in ethnic groups. Can J Cardiol. 2004 Apr;20(5):511-5.</citation>
    <PMID>15100753</PMID>
  </reference>
  <reference>
    <citation>Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999 Jul 1;341(1):1-7.</citation>
    <PMID>10387935</PMID>
  </reference>
  <reference>
    <citation>Flack JM, Kvasnicka JH, Gardin JM, Gidding SS, Manolio TA, Jacobs DR Jr. Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults: the CARDIA study. Am Heart J. 1999 Sep;138(3 Pt 1):486-92.</citation>
    <PMID>10467199</PMID>
  </reference>
  <reference>
    <citation>Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, Frye RL. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996 Nov 7;335(19):1417-23.</citation>
    <PMID>8875918</PMID>
  </reference>
  <reference>
    <citation>Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005 Mar 3;352(9):875-83.</citation>
    <PMID>15745978</PMID>
  </reference>
  <reference>
    <citation>Verma S, Mesana TG. Mitral-valve repair for mitral-valve prolapse. N Engl J Med. 2009 Dec 3;361(23):2261-9. doi: 10.1056/NEJMct0806111. Review.</citation>
    <PMID>19955526</PMID>
  </reference>
  <reference>
    <citation>Chan V, Malas T, Lapierre H, Boodhwani M, Lam BK, Rubens FD, Hendry PJ, Masters RG, Goldstein W, Mesana TG, Ruel M. Reoperation of left heart valve bioprostheses according to age at implantation. Circulation. 2011 Sep 13;124(11 Suppl):S75-80. doi: 10.1161/CIRCULATIONAHA.110.011973.</citation>
    <PMID>21911822</PMID>
  </reference>
  <reference>
    <citation>O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg. 2009 Jul;88(1 Suppl):S23-42. doi: 10.1016/j.athoracsur.2009.05.056.</citation>
    <PMID>19559823</PMID>
  </reference>
  <reference>
    <citation>Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg. 2009 Jul;88(1 Suppl):S43-62. doi: 10.1016/j.athoracsur.2009.05.055.</citation>
    <PMID>19559824</PMID>
  </reference>
  <reference>
    <citation>Ikonomidis JS, Kratz JM, Crumbley AJ 3rd, Stroud MR, Bradley SM, Sade RM, Crawford FA Jr. Twenty-year experience with the St Jude Medical mechanical valve prosthesis. J Thorac Cardiovasc Surg. 2003 Dec;126(6):2022-31.</citation>
    <PMID>14688722</PMID>
  </reference>
  <reference>
    <citation>Chan V, Jamieson WR, Lam BK, Ruel M, Ling H, Fradet G, Mesana TG. Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study. J Thorac Cardiovasc Surg. 2010 Nov;140(5):1053-8.e2. doi: 10.1016/j.jtcvs.2009.10.068. Epub 2010 May 23.</citation>
    <PMID>20546795</PMID>
  </reference>
  <reference>
    <citation>Chan V, Ruel M, Elmistekawy E, Mesana TG. Determinants of left ventricular dysfunction after repair of chronic asymptomatic mitral regurgitation. Ann Thorac Surg. 2015 Jan;99(1):38-42. doi: 10.1016/j.athoracsur.2014.07.025. Epub 2014 Nov 6.</citation>
    <PMID>25442982</PMID>
  </reference>
  <reference>
    <citation>Chan V, Ruel M, Hynes M, Chaudry S, Mesana TG. Impact of mitral annular calcification on early and late outcomes following mitral valve repair of myxomatous degeneration. Interact Cardiovasc Thorac Surg. 2013 Jul;17(1):120-5. doi: 10.1093/icvts/ivt163. Epub 2013 Apr 14.</citation>
    <PMID>23587525</PMID>
  </reference>
  <reference>
    <citation>Chan V, Ruel M, Chaudry S, Lambert S, Mesana TG. Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease. J Thorac Cardiovasc Surg. 2012 Apr;143(4 Suppl):S8-11. doi: 10.1016/j.jtcvs.2012.01.046. Epub 2012 Feb 4.</citation>
    <PMID>22306213</PMID>
  </reference>
  <reference>
    <citation>Castillo JG, Anyanwu AC, Fuster V, Adams DH. A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg. 2012 Aug;144(2):308-12. doi: 10.1016/j.jtcvs.2011.12.054. Epub 2012 Jun 12.</citation>
    <PMID>22698565</PMID>
  </reference>
  <reference>
    <citation>Carpentier A. Cardiac valve surgery--the &quot;French correction&quot;. J Thorac Cardiovasc Surg. 1983 Sep;86(3):323-37.</citation>
    <PMID>6887954</PMID>
  </reference>
  <reference>
    <citation>Braunberger E, Deloche A, Berrebi A, Abdallah F, Celestin JA, Meimoun P, Chatellier G, Chauvaud S, Fabiani JN, Carpentier A. Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation. 2001 Sep 18;104(12 Suppl 1):I8-11.</citation>
    <PMID>11568021</PMID>
  </reference>
  <reference>
    <citation>Filsoufi F, Carpentier A. Principles of reconstructive surgery in degenerative mitral valve disease. Semin Thorac Cardiovasc Surg. 2007 Summer;19(2):103-10. Review.</citation>
    <PMID>17870003</PMID>
  </reference>
  <reference>
    <citation>Kuperstein R, Spiegelstein D, Rotem G, Stein M, Kogan A, Sternik L, Raanani E. Late clinical outcome of transient intraoperative systolic anterior motion post mitral valve repair. J Thorac Cardiovasc Surg. 2015 Feb;149(2):471-6. doi: 10.1016/j.jtcvs.2014.10.043. Epub 2014 Oct 14.</citation>
    <PMID>25454906</PMID>
  </reference>
  <reference>
    <citation>Seeburger J, Falk V, Borger MA, Passage J, Walther T, Doll N, Mohr FW. Chordae replacement versus resection for repair of isolated posterior mitral leaflet prolapse: Ã  Ã¨galitÃ©. Ann Thorac Surg. 2009 Jun;87(6):1715-20. doi: 10.1016/j.athoracsur.2009.03.003.</citation>
    <PMID>19463584</PMID>
  </reference>
  <reference>
    <citation>Falk V, Seeburger J, Czesla M, Borger MA, Willige J, Kuntze T, Doll N, Borger F, Perrier P, Mohr FW. How does the use of polytetrafluoroethylene neochordae for posterior mitral valve prolapse (loop technique) compare with leaflet resection? A prospective randomized trial. J Thorac Cardiovasc Surg. 2008 Nov;136(5):1205; discussion 1205-6. doi: 10.1016/j.jtcvs.2008.07.028. Epub 2008 Sep 14.</citation>
    <PMID>19026803</PMID>
  </reference>
  <reference>
    <citation>Lange R, Guenther T, Noebauer C, Kiefer B, Eichinger W, Voss B, Bauernschmitt R, Tassani-Prell P, Mazzitelli D. Chordal replacement versus quadrangular resection for repair of isolated posterior mitral leaflet prolapse. Ann Thorac Surg. 2010 Apr;89(4):1163-70; discussion 1170. doi: 10.1016/j.athoracsur.2009.12.057.</citation>
    <PMID>20338326</PMID>
  </reference>
  <reference>
    <citation>Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jun 10;63(22):2438-88. doi: 10.1016/j.jacc.2014.02.537. Epub 2014 Mar 3. Erratum in: J Am Coll Cardiol. 2014 Jun 10;63(22):2489.</citation>
    <PMID>24603192</PMID>
  </reference>
  <reference>
    <citation>Chan KL, Chen SY, Chan V, Hay K, Mesana T, Lam BK. Functional significance of elevated mitral gradients after repair for degenerative mitral regurgitation. Circ Cardiovasc Imaging. 2013 Nov;6(6):1041-7. doi: 10.1161/CIRCIMAGING.112.000688. Epub 2013 Sep 6.</citation>
    <PMID>24014825</PMID>
  </reference>
  <reference>
    <citation>Mesana TG, Lam BK, Chan V, Chen K, Ruel M, Chan K. Clinical evaluation of functional mitral stenosis after mitral valve repair for degenerative disease: potential affect on surgical strategy. J Thorac Cardiovasc Surg. 2013 Dec;146(6):1418-23; discussion 1423-5. doi: 10.1016/j.jtcvs.2013.08.011. Epub 2013 Sep 26.</citation>
    <PMID>24075470</PMID>
  </reference>
  <reference>
    <citation>Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS, O'Brien SM, Brown JM. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2009 May;87(5):1431-7; discussion 1437-9. doi: 10.1016/j.athoracsur.2009.01.064.</citation>
    <PMID>19379881</PMID>
  </reference>
  <reference>
    <citation>Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63.</citation>
    <PMID>16376782</PMID>
  </reference>
  <reference>
    <citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. Erratum in: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.</citation>
    <PMID>12091180</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>September 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2015</study_first_posted>
  <last_update_submitted>February 3, 2017</last_update_submitted>
  <last_update_submitted_qc>February 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Mitral Valve Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

